Patient perspectives on management of pneumothorax in lymphangioleiomyomatosis

Chest

Volumn 129, Issue 5, 2006, Pages 1267-1273

  Young, Lisa R ^a,e   Almoosa, Khalid F ^a   Pollock BarZiv, Stacey ^b   Coutinho, Meg ^c   McCormack, Francis X ^a   Sahn, Steven A ^d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c The LAM Foundation   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Lymphangioleiomyomatosis; Pleurodesis; Pneumothorax; Shared decision making; Tube thoracostomy; Tuberous sclerosis

Indexed keywords

ADULT; ARTICLE; DATA BASE; DOCTOR PATIENT RELATION; EVALUATION; HUMAN; LIFESTYLE; LUNG FUNCTION; LYMPHANGIOLEIOMYOMATOSIS; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; OXYGEN THERAPY; PAIN; PERCEPTION; PLEURODESIS; PRIORITY JOURNAL; QUESTIONNAIRE; SPONTANEOUS PNEUMOTHORAX; THORAX RADIOGRAPHY; TUBE;

EID: 33646474836     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.5.1267     Document Type: Article

References (25)

1. Sullivan EJ. Lymphangioleiomyomatosis: a review. Chest 1998; 114:1689-1703
2. Franz DN, Brody A, Meyer C, et al. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med 2001; 164:661-668
3. Moss J, Avila NA, Barnes PM, et al. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med 2001; 164:669-671
4. Costello LC, Hartman TE, Ryu JH. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc 2000; 75:591-594
5. Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A 2000; 97:6085-6090
6. Kalassian KG, Doyle R, Kao P, et al. Lymphangioleiomyomatosis: new insights. Am J Respir Crit Care Med 1997; 155:1183-1186
7. Urban T, Lazor R, Lacronique J, et al. Pulmonary lymphangioleiomyomatosis: a study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P) Medicine (Baltimore) 1999; 78: 321-337
8. Johnson SR, Tattersfield AE. Clinical experience of lymphangioleiomyomatosis in the UK. Thorax 2000; 55:1052-1057
9. Taylor JR, Ryu J, Colby TV, et al. Lymphangioleiomyomatosis: clinical course in 32 patients. N Engl J Med 1990; 323:1254-1260
10. Almoosa K, Mendez J, Huggins JT, et al. Pneumothorax in lymphangioleiomyomatosis [abstract]. Am J Respir Crit Care Med 2004; 169:A618
11. Boehler A, Speich R, Russi EW, et al. Lung transplantation for lymphangioleiomyomatosis. N Engl J Med 1996; 335: 1275-1280
12. Pechet TT, Meyers BF, Guthrie TJ, et al. Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant 2004; 23:301-308
13. Baumann MH, Strange C, Heffner JE, et al. Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest 2001; 119: 590-602
14. Mendez JL, Nadrous HF, Vassallo R, et al. Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest 2004; 125; 1028-1032
15. Hatz RA, Kaps MF, Meimarakis G, et al. Long-term results after video-assisted-thoracoscopic surgery for first-time and recurrent spontaneous pneumothorax. Ann Thorac Surg 2000; 70:253-257
16. Massard G, Thomas P, Wihlm JM. Minimally invasive management for first and recurrent pneumothorax. Ann Thorac Surg 1998; 66:592-599
17. Almoosa KF, Ryu JH, Mendez J, et al. Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation. Chest 2006 (in press)
18. Cohen MM, Pollock-Barziv S, Johnson SR. Emerging clinical picture of lymphangioleiomyomatosis. Thorax 2005; 60:875-879
19. Chambers CV, Markson L, Diamond JJ, et al. Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respir Med 1999; 93: 88-94
20. Cohen D. Longo MF, Hood K, et al. Resource effects of training general practitioners in risk communication skills and shared decision making competences. J Eval Clin Pract 2004; 10:439-445
21. Heisler M, Vijan S, Anderson RM, et al. When do patients and their physicians agree on diabetes treatment goals and strategies, and what difference does it make? J Gen Intern Med 2003; 18:893-902
22. Cykert S. Risk acceptance and risk aversion: patients' perspectives on lung surgery. Thorac Surg Clin 2004; 14:287-293
23. Hirose T, Horichi N, Ohmori T, et al. Patients preferences in chemotherapy for advanced non-small-cell lung cancer. Intern Med 2005; 44:107-113
24. O'Connor AM, Drake ER, Fiset V, et al. The Ottawa patient decision aids. Eff Clin Pract 1999; 2:163-170
25. Thompson BT, Cox PN, Antonelli M, et al. Challenges in end-of-life care in the ICU: statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003: executive summary. Crit Care Med 2004; 32: 1781-1784